Synthesis and Evaluation of Compounds Containing 4-arylpiperazinyl Moieties Linked to a 2-(pyridin-3-yl)-1H-benzimidazole as p38 MAP Kinase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|7|691-696

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.7, 2016-08, pp. : 691-696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and Biological Evaluation of Novel N-[(7-pyridin-4-yl-2, 3- dihydro-benzofuran-2-yl) Methyl]-(4-methyl-1, 2, 3-thiadiazole-5-yl) Formamide as a Potent Immunosuppressant Agent

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 3, 2014-01 ,pp. : 375-379

Bentham Science Publishers

Access to resources Recommend Favorite

Pyridinylimidazole Based p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite

P38 MAP Kinase Inhibitors: Evolution of Imidazole-Based and Pyrido- Pyrimidin-2-One Lead Classes

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-09 ,pp. : 987-1003

Bentham Science Publishers

Access to resources Recommend Favorite

Protease inhibitors - Part 3. Synthesis of non-basic thrombin inhibitors incorporating pyridinium-sulfanilylguanidine moieties at the P1 site

By Scozzafava A.   Briganti F.   Supuran C.T.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 11, 1999-11 ,pp. : 939-952

Elsevier

Access to resources Recommend Favorite

The Non-Diaryl Heterocycle Classes of p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1021-1035

Bentham Science Publishers

Access to resources Recommend Favorite